DERM
Journey Medical Corp
NASDAQ: DERM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.15
+3.00% today
Updated 2026-04-30
Market cap
$171.27M
P/E ratio
—
P/S ratio
2.77x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$4 – $10
Volume
0.2M
Journey Medical Corp (DERM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-18.50%
Operating margin
-2.76%
ROE
-44.00%
ROA
-5.84%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $7.30M | $-31.88M | 100.00% | -434.22% | -436.64% |
| 2015 | $7.30M | $-78.40M | 100.00% | -1,092.74% | -1,073.96% |
| 2016 | $22.59M | $-89.08M | 100.00% | -401.26% | -394.44% |
| 2017 | $4.54M | $-303.26M | 100.00% | -6,613.65% | -6,678.29% |
| 2018 | $42.34M | $-221.54M | 97.22% | -505.40% | -523.25% |
| 2019 | $34.92M | $3.63M | 69.84% | 15.06% | 10.38% |
| 2020 | $44.53M | $5.28M | 67.23% | 17.63% | 11.86% |
| 2021 | $63.13M | $-43.99M | 49.18% | -55.25% | -69.68% |
| 2022 | $73.67M | $-29.63M | 58.23% | -37.35% | -40.22% |
| 2023 | $79.18M | $-3.85M | 66.33% | -2.62% | -4.87% |
| 2024 | $56.13M | $-14.67M | 62.81% | -24.36% | -26.14% |
| 2025 | $61.86M | $-11.43M | 59.29% | -13.21% | -18.48% |